These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16891068)
1. Adriamycin release from self-assembling nanospheres of poly(DL-lactide-co-glycolide)-grafted pullulan. Jeong YI; Na HS; Oh JS; Choi KC; Song CE; Lee HC Int J Pharm; 2006 Sep; 322(1-2):154-60. PubMed ID: 16891068 [TBL] [Abstract][Full Text] [Related]
2. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
3. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications. Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers. Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
6. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier. Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109 [TBL] [Abstract][Full Text] [Related]
7. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate. Yin J; Noda Y; Yotsuyanagi T Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494 [TBL] [Abstract][Full Text] [Related]
8. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647 [TBL] [Abstract][Full Text] [Related]
9. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534 [TBL] [Abstract][Full Text] [Related]
10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
11. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Lin R; Shi Ng L; Wang CH Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377 [TBL] [Abstract][Full Text] [Related]
12. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. Jeong YI; Choi KC; Song CE Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768 [TBL] [Abstract][Full Text] [Related]
14. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy. Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746 [TBL] [Abstract][Full Text] [Related]
15. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
16. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Tahara K; Furukawa S; Yamamoto H; Kawashima Y Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023 [TBL] [Abstract][Full Text] [Related]
17. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation. Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238 [TBL] [Abstract][Full Text] [Related]
18. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour. Unger F; Wittmar M; Morell F; Kissel T Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641 [TBL] [Abstract][Full Text] [Related]
19. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation. Jevtić M; Radulović A; Ignjatović N; Mitrić M; Uskoković D Acta Biomater; 2009 Jan; 5(1):208-18. PubMed ID: 18753023 [TBL] [Abstract][Full Text] [Related]
20. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment. Wang Y; Challa P; Epstein DL; Yuan F Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]